2016-03-05T00:00:00.000-05:00
Exchange Commission,0.382726
transaction,-0.230123
quarter worth,0.322993
strong buy rating,0.414391
Boston Advisors,0.440401
recent quarter,0.37274
Valley Investment Advisors,-0.523474
PGGM Investments,0.333616
Company LLC,0.35479
stock,0.105023
Hudson Valley Investment,-0.523474
InvestorPlace Broker Center,0.555736
Nordea Investment Management,0.394355
chief operating officer,0.207524
firm’s stock,-0.230123
Janus Capital Management,0.369121
biopharmaceutical company,0.46164
personal trading style,0.598412
research-based biopharmaceutical company,0.642682
ex-dividend date,-0.33715
Investment Management AB,0.394355
Gilead Sciences Inc.,0.555178
COO John F.,-0.230123
average price,0.170518
shares,0.159157
consensus estimate,0.351847
concise daily summary,0.447788
average target price,-0.323452
Gilead Sciences,0.186764
stock broker,0.245696
consensus rating,0.435093
recent Form,0.382726
Verde Servico Internacionais,0.31237
new position,0.322993
chronic hepatitis,-0.646567
quarter,-0.0460201
